UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Milk‐derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis

British journal of clinical pharmacology, 2017-01, Vol.83 (1), p.152-162

2017

Volltextzugriff (PDF)

Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions

Blood, 2004-03, Vol.103 (6), p.2096-2104

2004

Volltextzugriff (PDF)

Proteomic identification of the candidate target proteins of 15-deoxy-delta12,14-prostaglandin J2

Proteomics (Weinheim), 2013-07, Vol.13 (14), p.2135-2139

2013

Volltextzugriff (PDF)

Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers

Stroke (1970), 2006-08, Vol.37 (8), p.2153-2158

2006

Volltextzugriff (PDF)

Ticlopidine and clopidogrel

Circulation (New York, N.Y.), 1999-10, Vol.100 (15), p.1667-1672

1999

Volltextzugriff (PDF)

Moderation of the platelet releasate response by aspirin

Blood, 2007-06, Vol.109 (11), p.4786-4792

2007

Volltextzugriff (PDF)

Canonical Wnt signaling in megakaryocytes regulates proplatelet formation

Blood, 2013-01, Vol.121 (1), p.188-196

2013

Volltextzugriff (PDF)

Macrophage PPAR gamma Co‐activator‐1 alpha participates in repressing foam cell formation and atherosclerosis in response to conjugated linoleic acid

EMBO molecular medicine, 2013-09, Vol.5 (9), p.1443-1457

2013

Volltextzugriff (PDF)

Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine–aspartate repeat protein SdrE and protein A

Molecular microbiology, 2002-05, Vol.44 (4), p.1033-1044

2002

Volltextzugriff (PDF)

Canonical Wnt Signaling Negatively Regulates Platelet Function

Proceedings of the National Academy of Sciences - PNAS, 2009-11, Vol.106 (47), p.19836-19841

2009

Volltextzugriff (PDF)

Lack of Bioequivalence Among Low‐dose, Enteric‐coated Aspirin Preparations

Clinical pharmacology and therapeutics, 2018-06, Vol.103 (6), p.1047-1051

2018

Volltextzugriff (PDF)

Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis

Circulation (New York, N.Y.), 2003-12, Vol.108 (24), p.3017-3023

2003

Volltextzugriff (PDF)

WNT-3a modulates platelet function by regulating small GTPase activity

FEBS letters, 2012-07, Vol.586 (16), p.2267-2272

2012

Volltextzugriff (PDF)

Aspirin and clopidogrel resistance

Hematology, 2007, Vol.2007 (1), p.114-120

2007

Volltextzugriff (PDF)

A Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension

Circulation research, 2018-06, Vol.122 (12), p.1689-1702

2018

Volltextzugriff (PDF)

Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer

BMC cancer, 2009-06, Vol.9 (1), p.207-207

2009

Volltextzugriff (PDF)

Identification of the phosphotyrosine proteome from thrombin activated platelets

Proteomics (Weinheim), 2002-06, Vol.2 (6), p.642-648

2002

Volltextzugriff (PDF)

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease

Circulation (New York, N.Y.), 2007-04, Vol.115 (16), p.2196-2207

2007

Volltextzugriff (PDF)

Contribution of cyclooxygenase-1 to thromboxane formation, platelet–vessel wall interactions and atherosclerosis in the ApoE null mouse

Atherosclerosis, 2009-01, Vol.202 (1), p.84-91

2009

Volltextzugriff (PDF)

Historical Lessons in Translational Medicine: Cyclooxygenase Inhibition and P2Y12 Antagonism

Circulation research, 2013-01, Vol.112 (1), p.174-194

2013

Volltextzugriff (PDF)

Aspirin and coronary artery disease

Thrombosis and haemostasis, 2004-12, Vol.92 (6), p.1175-1181

2004

Volltextzugriff (PDF)

Cyclooxygenase-2-linked attenuation of hypoxia-induced pulmonary hypertension and intravascular thrombosis

The Journal of pharmacology and experimental therapeutics, 2008-07, Vol.326 (1), p.51-58

2008

Volltextzugriff (PDF)

Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes: The Lessons From Antagonizing the Cellular Effects of Thrombin-Acute Coronary Syndromes Trial

Circulation (New York, N.Y.), 2011-05, Vol.123 (17), p.1843-1853

2011

Volltextzugriff (PDF)

Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease: The Lessons From Antagonizing the Cellular Effect of Thrombin-Coronary Artery Disease Trial

Circulation (New York, N.Y.), 2011-05, Vol.123 (17), p.1854-1863

2011

Volltextzugriff (PDF)

Milk-derived bioactive peptides inhibit human endothelial-monocyte interactions via PPAR-γ dependent regulation of NF-κB

Journal of inflammation (London, England), 2015, Vol.12 (1), p.1-1

2015

Volltextzugriff (PDF)

1 – 25 von 310

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(271)
Mit Volltextzugriff
(214)

Publikationsform

Sprache

Englisch
(304)
Deutsch
(5)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(121)
Life Sciences & Biomedicine
(113)
Humans
(106)
Biological And Medical Sciences
(56)
Medical Sciences
(50)
Male
(45)
Cardiovascular System & Cardiology
(40)
Animals
(39)
Female
(39)
Cardiac & Cardiovascular Systems
(35)
Middle Aged
(29)
Aged
(26)
Cardiology. Vascular System
(26)
Peripheral Vascular Disease
(23)
Adult
(21)
Hematology
(20)
Pharmacology & Pharmacy
(19)
Platelet Aggregation Inhibitors - Pharmacology
(19)
Blood Platelets - Drug Effects
(18)
Blood Platelets - Metabolism
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Milk‐derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis

Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions

Proteomic identification of the candidate target proteins of 15-deoxy-delta12,14-prostaglandin J2

Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers

Ticlopidine and clopidogrel

Moderation of the platelet releasate response by aspirin

Canonical Wnt signaling in megakaryocytes regulates proplatelet formation

Macrophage PPAR gamma Co‐activator‐1 alpha participates in repressing foam cell formation and atherosclerosis in response to conjugated linoleic acid

Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine–aspartate repeat protein SdrE and protein A

Canonical Wnt Signaling Negatively Regulates Platelet Function

Lack of Bioequivalence Among Low‐dose, Enteric‐coated Aspirin Preparations

Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis

WNT-3a modulates platelet function by regulating small GTPase activity

Aspirin and clopidogrel resistance

A Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension

Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer

Identification of the phosphotyrosine proteome from thrombin activated platelets

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease

Contribution of cyclooxygenase-1 to thromboxane formation, platelet–vessel wall interactions and atherosclerosis in the ApoE null mouse

Historical Lessons in Translational Medicine: Cyclooxygenase Inhibition and P2Y12 Antagonism

Aspirin and coronary artery disease

Cyclooxygenase-2-linked attenuation of hypoxia-induced pulmonary hypertension and intravascular thrombosis

Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes: The Lessons From Antagonizing the Cellular Effects of Thrombin-Acute Coronary Syndromes Trial

Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease: The Lessons From Antagonizing the Cellular Effect of Thrombin-Coronary Artery Disease Trial

Milk-derived bioactive peptides inhibit human endothelial-monocyte interactions via PPAR-γ dependent regulation of NF-κB

Suchergebnisse filtern